_id
6911c836ccc777a4e85d6644
Ticker
HTSUY
Name
Hisamitsu Pharmaceutical Company Inc Unsponsored ADR
Exchange
OTCGREY
Address
-
Country
USA
Sector
Other
Industry
Other
Currency
USD
Website
-
Description
Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals. It offers SALONPAS pain relief products in the form of patches, sprays, gels, creams, liniments, and lotions; SALONSIP gel patches and heat pads; ByeBye-FEVER, a cooling gel sheet for fever discomfort in babies, children, and adults; Lifecella facial and gel sheet masks; and MOHRUS and KEPLAT pain relieving patches. The company sells its products in North America, Central and South America, Asia, Oceania, the Middle East, Africa, and Europe. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Last Close
6.65
Volume
-
Current Price
6.65
Change
0
Last Updated
2026-01-04T14:46:22.444Z
Image
-
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-08-31
Revenue
39646000000
Cost Of Revenue
16042000000
Gross Profit
23604000000
Operating Expenses
34789000000
Operating Income
4857000000
Interest Expense
12000000
Pretax Income
6186000000
Net Income
4310000000
Eps
58.76518769914547
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-
Operating Margin
12.250920647732432
Total Other Income Expense Net
-
Cash
113572000000
Short Term Investments
9164000000
Receivables
51878000000
Inventories
23004000000
Total Current Assets
207043000000
Property Plant Equipment
58828000000
Total Assets
350477000000
Payables
13101000000
Short Term Debt
-
Long Term Debt
46000000
Total Liabilities
74553000000
Equity
273572000000
Bs_currency_symbol
JPY
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
JPY
PE
-
PB
0.0017828185424677966
ROE
1.5754536282952936
ROA
1.2297525943214533
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
48
Deep Value Investing Score
5.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
3.5
Growth Investing Score
2.5
Momentum Investing Score
5.5
Net Net Investing Score
2
Quality Investing Score
5.5
Value Investing Score
7.5
Quarters > 0 > quarter
2024-08-31
Quarters > 0 > income Statement > revenue
39646000000
Quarters > 0 > income Statement > cost Of Revenue
16042000000
Quarters > 0 > income Statement > gross Profit
23604000000
Quarters > 0 > income Statement > operating Expenses
34789000000
Quarters > 0 > income Statement > operating Income
4857000000
Quarters > 0 > income Statement > interest Expense
12000000
Quarters > 0 > income Statement > pretax Income
6186000000
Quarters > 0 > income Statement > net Income
4310000000
Quarters > 0 > income Statement > eps
58.76518769914547
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
73342742
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
12.250920647732432
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
JPY
Quarters > 0 > balance Sheet > cash
113572000000
Quarters > 0 > balance Sheet > short Term Investments
9164000000
Quarters > 0 > balance Sheet > receivables
51878000000
Quarters > 0 > balance Sheet > inventories
23004000000
Quarters > 0 > balance Sheet > total Current Assets
207043000000
Quarters > 0 > balance Sheet > property Plant Equipment
58828000000
Quarters > 0 > balance Sheet > total Assets
350477000000
Quarters > 0 > balance Sheet > payables
13101000000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
46000000
Quarters > 0 > balance Sheet > total Liabilities
74553000000
Quarters > 0 > balance Sheet > equity
273572000000
Quarters > 0 > balance Sheet > currency_symbol
JPY
Quarters > 0 > cash Flow > net Income
4310000000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
JPY
Quarters > 0 > ratios > PE
58.76518769914547
Quarters > 0 > ratios > PB
0.0017828185424677966
Quarters > 0 > ratios > ROE
1.5754536282952936
Quarters > 0 > ratios > ROA
1.2297525943214533
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
48
Quarters > 1 > quarter
2024-05-31
Quarters > 1 > income Statement > revenue
35810000000
Quarters > 1 > income Statement > cost Of Revenue
15005000000
Quarters > 1 > income Statement > gross Profit
20804000000
Quarters > 1 > income Statement > operating Expenses
31660000000
Quarters > 1 > income Statement > operating Income
4149000000
Quarters > 1 > income Statement > interest Expense
4000000
Quarters > 1 > income Statement > pretax Income
6915000000
Quarters > 1 > income Statement > net Income
4788000000
Quarters > 1 > income Statement > eps
65.28220222555589
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
73343114
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
11.586149120357442
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
JPY
Quarters > 1 > balance Sheet > cash
112288000000
Quarters > 1 > balance Sheet > short Term Investments
10393000000
Quarters > 1 > balance Sheet > receivables
42296000000
Quarters > 1 > balance Sheet > inventories
22719000000
Quarters > 1 > balance Sheet > total Current Assets
194680000000
Quarters > 1 > balance Sheet > property Plant Equipment
57617000000
Quarters > 1 > balance Sheet > total Assets
338839000000
Quarters > 1 > balance Sheet > payables
8899000000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
59000000
Quarters > 1 > balance Sheet > total Liabilities
71979000000
Quarters > 1 > balance Sheet > equity
264577000000
Quarters > 1 > balance Sheet > currency_symbol
JPY
Quarters > 1 > cash Flow > net Income
4788000000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
JPY
Quarters > 1 > ratios > PE
65.28220222555589
Quarters > 1 > ratios > PB
0.0018434395586162063
Quarters > 1 > ratios > ROE
1.8096811136266568
Quarters > 1 > ratios > ROA
1.4130604800509978
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
48
Quarters > 2 > quarter
2024-02-29
Quarters > 2 > income Statement > revenue
38879000000
Quarters > 2 > income Statement > cost Of Revenue
18508000000
Quarters > 2 > income Statement > gross Profit
20370000000
Quarters > 2 > income Statement > operating Expenses
37981000000
Quarters > 2 > income Statement > operating Income
897000000
Quarters > 2 > income Statement > interest Expense
6000000
Quarters > 2 > income Statement > pretax Income
2527000000
Quarters > 2 > income Statement > net Income
1859000000
Quarters > 2 > income Statement > eps
24.54348523352235
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
75743114
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
2.307158105918362
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
JPY
Quarters > 2 > balance Sheet > cash
112459000000
Quarters > 2 > balance Sheet > short Term Investments
12862000000
Quarters > 2 > balance Sheet > receivables
43237000000
Quarters > 2 > balance Sheet > inventories
21176000000
Quarters > 2 > balance Sheet > total Current Assets
194022000000
Quarters > 2 > balance Sheet > property Plant Equipment
49462000000
Quarters > 2 > balance Sheet > total Assets
328779000000
Quarters > 2 > balance Sheet > payables
9612000000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
76000000
Quarters > 2 > balance Sheet > total Liabilities
61703000000
Quarters > 2 > balance Sheet > equity
264871000000
Quarters > 2 > balance Sheet > currency_symbol
JPY
Quarters > 2 > cash Flow > net Income
1859000000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
JPY
Quarters > 2 > ratios > PE
24.54348523352235
Quarters > 2 > ratios > PB
0.0019016491352394185
Quarters > 2 > ratios > ROE
0.7018510897757777
Quarters > 2 > ratios > ROA
0.5654254073404932
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
54
Quarters > 3 > quarter
2023-11-30
Quarters > 3 > income Statement > revenue
35850000000
Quarters > 3 > income Statement > cost Of Revenue
15897000000
Quarters > 3 > income Statement > gross Profit
19954000000
Quarters > 3 > income Statement > operating Expenses
31977000000
Quarters > 3 > income Statement > operating Income
3874000000
Quarters > 3 > income Statement > interest Expense
5000000
Quarters > 3 > income Statement > pretax Income
5021000000
Quarters > 3 > income Statement > net Income
3693000000
Quarters > 3 > income Statement > eps
48.52203306293698
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
76109754
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
10.806136680613667
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
JPY
Quarters > 3 > balance Sheet > cash
111141000000
Quarters > 3 > balance Sheet > short Term Investments
12771000000
Quarters > 3 > balance Sheet > receivables
42412000000
Quarters > 3 > balance Sheet > inventories
21606000000
Quarters > 3 > balance Sheet > total Current Assets
200181000000
Quarters > 3 > balance Sheet > property Plant Equipment
51025000000
Quarters > 3 > balance Sheet > total Assets
334909000000
Quarters > 3 > balance Sheet > payables
10052000000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
95000000
Quarters > 3 > balance Sheet > total Liabilities
63417000000
Quarters > 3 > balance Sheet > equity
269082000000
Quarters > 3 > balance Sheet > currency_symbol
JPY
Quarters > 3 > cash Flow > net Income
3693000000
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
JPY
Quarters > 3 > ratios > PE
48.52203306293698
Quarters > 3 > ratios > PB
0.0018809502831850515
Quarters > 3 > ratios > ROE
1.3724440876758757
Quarters > 3 > ratios > ROA
1.102687595734961
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
51
Annuals > 0 > quarter
2025-02-28
Annuals > 0 > income Statement > revenue
156006000000
Annuals > 0 > income Statement > cost Of Revenue
64810000000
Annuals > 0 > income Statement > gross Profit
91196000000
Annuals > 0 > income Statement > operating Expenses
137110000000
Annuals > 0 > income Statement > operating Income
18896000000
Annuals > 0 > income Statement > interest Expense
23000000
Annuals > 0 > income Statement > pretax Income
28687000000
Annuals > 0 > income Statement > net Income
21758000000
Annuals > 0 > income Statement > eps
298.2068882035835
Annuals > 0 > income Statement > dividends Per Share
6519000000
Annuals > 0 > income Statement > shares Outstanding
72962768
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
12.112354653026165
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
JPY
Annuals > 0 > balance Sheet > cash
114518000000
Annuals > 0 > balance Sheet > short Term Investments
14598000000
Annuals > 0 > balance Sheet > receivables
47223000000
Annuals > 0 > balance Sheet > inventories
22391000000
Annuals > 0 > balance Sheet > total Current Assets
203788000000
Annuals > 0 > balance Sheet > property Plant Equipment
59899000000
Annuals > 0 > balance Sheet > total Assets
343068000000
Annuals > 0 > balance Sheet > payables
9910000000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
1694000000
Annuals > 0 > balance Sheet > total Liabilities
63665000000
Annuals > 0 > balance Sheet > equity
276822000000
Annuals > 0 > balance Sheet > currency_symbol
JPY
Annuals > 0 > cash Flow > net Income
21758000000
Annuals > 0 > cash Flow > depreciation
6335000000
Annuals > 0 > cash Flow > change In Working Capital
-6330000000
Annuals > 0 > cash Flow > cash From Operations
18765000000
Annuals > 0 > cash Flow > capital Expenditures
13774000000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
23414000000
Annuals > 0 > cash Flow > currency_symbol
JPY
Annuals > 0 > ratios > PE
298.2068882035835
Annuals > 0 > ratios > PB
0.0017527595610175493
Annuals > 0 > ratios > ROE
7.859924427971765
Annuals > 0 > ratios > ROA
6.342182890855458
Annuals > 0 > ratios > FCF
4991000000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.031992359268233274
Annuals > 0 > health Score
49
Annuals > 1 > quarter
2024-02-29
Annuals > 1 > income Statement > revenue
141706000000
Annuals > 1 > income Statement > cost Of Revenue
62735000000
Annuals > 1 > income Statement > gross Profit
78970000000
Annuals > 1 > income Statement > operating Expenses
128538000000
Annuals > 1 > income Statement > operating Income
13167000000
Annuals > 1 > income Statement > interest Expense
18000000
Annuals > 1 > income Statement > pretax Income
19186000000
Annuals > 1 > income Statement > net Income
13969000000
Annuals > 1 > income Statement > eps
184.42600603930808
Annuals > 1 > income Statement > dividends Per Share
6578000000
Annuals > 1 > income Statement > shares Outstanding
75743114
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
9.29177310770186
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
JPY
Annuals > 1 > balance Sheet > cash
112459000000
Annuals > 1 > balance Sheet > short Term Investments
12862000000
Annuals > 1 > balance Sheet > receivables
43237000000
Annuals > 1 > balance Sheet > inventories
21176000000
Annuals > 1 > balance Sheet > total Current Assets
194022000000
Annuals > 1 > balance Sheet > property Plant Equipment
49462000000
Annuals > 1 > balance Sheet > total Assets
328779000000
Annuals > 1 > balance Sheet > payables
9612000000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
76000000
Annuals > 1 > balance Sheet > total Liabilities
61703000000
Annuals > 1 > balance Sheet > equity
264871000000
Annuals > 1 > balance Sheet > currency_symbol
JPY
Annuals > 1 > cash Flow > net Income
13969000000
Annuals > 1 > cash Flow > depreciation
5172000000
Annuals > 1 > cash Flow > change In Working Capital
-1227000000
Annuals > 1 > cash Flow > cash From Operations
18188000000
Annuals > 1 > cash Flow > capital Expenditures
13036000000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
941000000
Annuals > 1 > cash Flow > currency_symbol
JPY
Annuals > 1 > ratios > PE
184.42600603930808
Annuals > 1 > ratios > PB
0.0019016491352394185
Annuals > 1 > ratios > ROE
5.273888043613684
Annuals > 1 > ratios > ROA
4.248750680548332
Annuals > 1 > ratios > FCF
5152000000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.03635696441929064
Annuals > 1 > health Score
47
Annuals > 2 > quarter
2023-02-28
Annuals > 2 > income Statement > revenue
128330000000
Annuals > 2 > income Statement > cost Of Revenue
55630000000
Annuals > 2 > income Statement > gross Profit
72699000000
Annuals > 2 > income Statement > operating Expenses
116729000000
Annuals > 2 > income Statement > operating Income
11600000000
Annuals > 2 > income Statement > interest Expense
15000000
Annuals > 2 > income Statement > pretax Income
16113000000
Annuals > 2 > income Statement > net Income
11742000000
Annuals > 2 > income Statement > eps
151.03351260255812
Annuals > 2 > income Statement > dividends Per Share
6719000000
Annuals > 2 > income Statement > shares Outstanding
77744335
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
9.039195823268138
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
JPY
Annuals > 2 > balance Sheet > cash
122154000000
Annuals > 2 > balance Sheet > short Term Investments
14714000000
Annuals > 2 > balance Sheet > receivables
40014000000
Annuals > 2 > balance Sheet > inventories
18922000000
Annuals > 2 > balance Sheet > total Current Assets
199174000000
Annuals > 2 > balance Sheet > property Plant Equipment
43209000000
Annuals > 2 > balance Sheet > total Assets
313917000000
Annuals > 2 > balance Sheet > payables
8351000000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
147000000
Annuals > 2 > balance Sheet > total Liabilities
55513000000
Annuals > 2 > balance Sheet > equity
256362000000
Annuals > 2 > balance Sheet > currency_symbol
JPY
Annuals > 2 > cash Flow > net Income
11742000000
Annuals > 2 > cash Flow > depreciation
4952000000
Annuals > 2 > cash Flow > change In Working Capital
-262000000
Annuals > 2 > cash Flow > cash From Operations
12727000000
Annuals > 2 > cash Flow > capital Expenditures
7908000000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-20822000000
Annuals > 2 > cash Flow > currency_symbol
JPY
Annuals > 2 > ratios > PE
151.03351260255812
Annuals > 2 > ratios > PB
0.002016678867187805
Annuals > 2 > ratios > ROE
4.580242001544691
Annuals > 2 > ratios > ROA
3.740479171245903
Annuals > 2 > ratios > FCF
4819000000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.03755162471752513
Annuals > 2 > health Score
46
Annuals > 3 > quarter
2022-02-28
Annuals > 3 > income Statement > revenue
120193000000
Annuals > 3 > income Statement > cost Of Revenue
50126000000
Annuals > 3 > income Statement > gross Profit
70067000000
Annuals > 3 > income Statement > operating Expenses
110856000000
Annuals > 3 > income Statement > operating Income
9337000000
Annuals > 3 > income Statement > interest Expense
20000000
Annuals > 3 > income Statement > pretax Income
12956000000
Annuals > 3 > income Statement > net Income
9658000000
Annuals > 3 > income Statement > eps
121.12226437283154
Annuals > 3 > income Statement > dividends Per Share
6839000000
Annuals > 3 > income Statement > shares Outstanding
79737611
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
7.768339254365896
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
JPY
Annuals > 3 > balance Sheet > cash
129290000000
Annuals > 3 > balance Sheet > short Term Investments
13141000000
Annuals > 3 > balance Sheet > receivables
38505000000
Annuals > 3 > balance Sheet > inventories
16412000000
Annuals > 3 > balance Sheet > total Current Assets
200176000000
Annuals > 3 > balance Sheet > property Plant Equipment
39069000000
Annuals > 3 > balance Sheet > total Assets
302858000000
Annuals > 3 > balance Sheet > payables
7533000000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
219000000
Annuals > 3 > balance Sheet > total Liabilities
47976000000
Annuals > 3 > balance Sheet > equity
253165000000
Annuals > 3 > balance Sheet > currency_symbol
JPY
Annuals > 3 > cash Flow > net Income
9658000000
Annuals > 3 > cash Flow > depreciation
4321000000
Annuals > 3 > cash Flow > change In Working Capital
4291000000
Annuals > 3 > cash Flow > cash From Operations
19199000000
Annuals > 3 > cash Flow > capital Expenditures
4193000000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
-5106000000
Annuals > 3 > cash Flow > currency_symbol
JPY
Annuals > 3 > ratios > PE
121.12226437283154
Annuals > 3 > ratios > PB
0.002094504031560445
Annuals > 3 > ratios > ROE
3.814903323919183
Annuals > 3 > ratios > ROA
3.1889532388115884
Annuals > 3 > ratios > FCF
15006000000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.124849200868603
Annuals > 3 > health Score
52
Valuation > metrics > PE
58.76518769914547
Valuation > metrics > PB
0.0017828185424677966
Valuation > final Score
40
Valuation > verdict
17.6% Overvalued
Profitability > metrics > ROE
1.5754536282952936
Profitability > metrics > ROA
2.081693174847737
Profitability > metrics > Net Margin
0.10871210210361701
Profitability > final Score
26
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.27251692424663343
Risk > metrics > Interest Coverage
404.75
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
15.803602778413861
Liquidity > metrics > Quick Ratio
14.047706281963208
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
100
Prev Valuations > 2
41.773560324475625
Prev Profitabilities > 0
31
Prev Profitabilities > 1
11
Prev Profitabilities > 2
24
Prev Risks > 0
100
Prev Risks > 1
100
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:59:43.201Z
Earnings History > 0 > period
2026-02-28
Earnings History > 0 > report Date
2026-04-08
Earnings History > 0 > date
2026-02-28
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-11-30
Earnings History > 1 > report Date
2026-01-07
Earnings History > 1 > date
2025-11-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals. It offers SALONPAS pain relief products in the form of patches, sprays, gels, creams, liniments, and lotions; SALONSIP gel patches and heat pads; ByeBye-FEVER, a cooling gel sheet for fever discomfort in babies, children, and adults; Lifecella facial and gel sheet masks; and MOHRUS and KEPLAT pain relieving patches. The company sells its products in North America, Central and South America, Asia, Oceania, the Middle East, Africa, and Europe. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2024-08-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Hisamitsu Pharmaceutical Company Inc Unsponsored ADR
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-02-28
EPS Estimate
—
Date
2025-11-30
EPS Actual
—
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-08-31)
(Last Updated 2024-08-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-08-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-08-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.